The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Hellenic Dynamic just posted on LinkedIn asking for questions to be answered by Davinder Rai next week. click on the link below and ask your questions.
https://www.linkedin.com/posts/hellenic-dynamics_lse-qanda-ceo-activity-7079501242518884352-_NIt?utm_source=share&utm_medium=member_ios
My questions are as follows
1. Do you envisage doing a fund raise in the next 12 months
2. Do you have an operational license from the Greek Government for cultivation as described in your prospectus i.e a 2 stage process with stage 1 being an installation license.
3. When will the 1st crop be cultivated
Just posted on LinkedIn
Earlier this week, we announced an extension in our cultivation strategy as we look to pioneer ‘Cannabis 2.0’. Here are the key details ⬇️
🌍 The Medical cannabis market in Europe is rapidly evolving.
🌱 In the last 18 months, cultivators have been struggling with soaring energy costs that have put many out of business, whilst distributors have been building their own EU-GMP facilities, putting into question the need for Hellenic to develop a GMP facility of their own when our customers are already doing so.
💡 In response to this, Hellenic has identified an opportunity that they are uniquely placed to pounce on.
🔬 For the first time, we are offering distributors the opportunity to have their own dedicated cultivation facility by way of a Hellenic POD (“Product Outsourcing Development”).
🏢 Each POD is a fully indoor cultivation area of 1,000 square meters and is capable of producing circa 1,200 kg of medical cannabis flowers per annum.
🤝 Under the Hellenic POD strategy distributors can now fully define or supply the specific strains of medical cannabis they are looking to receive, which Hellenic cultivates and sends out directly to the distributor, branded under the distributors chosen brand name. Each POD can be taken for a minimum of two years.
💰 For distributors, only our facility offers such a low cost of production with such strong expertise, and for us, this new model removes the significant cost of building our own GMP facility, whilst allowing us to focus on leveraging one of our strongest assets, our site in Greece.
🏆 This simplifies our business model, saves us time and expense while maintaining our commitment to excellence and compliance.
🚀 Hellenic is well placed to become the engine room for the European Medical Cannabis market, and we have more exciting announcements on this latest extension soon.
Https://lnkd.in/exW9dH63
Click on the link and then press accept at the bottom of the page
Some big buys going through for 10million shares at a time! Someone is not put off by the RNS and if it’s the buyer who purchased the 2 x 75 million shares a few weeks back then I expect there will be a tr1 in the next few days
Pidster you obviously know very little about this company! I have held since it was uk spac, shortly after it was renamed from Mountfield. If you took some time and research the company i.e. the prospectus from when they listed it does say they will not need to raise further funds and everything is funded from sales